Sandoz Group reported higher sales for the second quarter, driven by a strong performance in its biosimilar segment and a return to growth in generics.
Source link
Sandoz Shares Climb After Biosimilar Sales Drive Growth
Date:
More like thisRelated
Theme Parks and ‘Toy Story 5’ Boost Disney Results
Third-quarter revenue increased 7% to $25.2 billion, driven by...
Transfer rumors, news: Spurs eye USMNT star Balogun, alongside Osimhen, Jackson
Tottenham Hotspur are tracking AS Monaco and USMNT striker...
Rep. Chuck Edwards drops re-election bid after censure recommendation over harassment claims
Rep. Chuck Edwards, R-N.C. has said he is dropping...
A pair of Lobos make preseason watch lists for football
ALBUQUERQUE, N.M. (KRQE) – Preseason watch lists are starting to...